Enzolytics Inc (OTCMKTS: ENZC) Appoints Steve Sharabura As Subsidiary President

July 30, 2021

Enzolytics Inc (OTCMKTS: ENZC), this week, announced hiring Steve Sharabura as its President for subsidiary RobustoMed, Inc. The subsidiary is based out of Atlanta. RobustoMed, Inc. shall kick off a new model for its business that will focus on developing opportunities for the international partnership. This pertains specifically to product companies and medical development stage drug candidates.  Role of new President for subsidiary Mr. Steve Sharabura is liable for driving…

Read More >>

Enzolytics Inc. (OTCMKTS: ENZC) Advancing its ITC-1 Anti-HIV Therapy to Clinical Trials under EMA Across Europe

July 27, 2021

Enzolytics Inc. (OTCMKTS: ENZC) has finalized plans to advance the previously tested ITV-1 anti-HIV treatment to clinical studies and supply across Europe. Completing the steps will establish the anti-HIV therapy as a potential revenue source, a significant milestone for Enzolytics’ profitability and human health.  Anti-HIV therapy progressing to clinical studies under EMA The anti-HIV therapy had progressed toward Bulgarian Drug Agency certification, but the process was halted before completion. But,…

Read More >>